packageSipuleucelT

sipuleucel-T

Extends from Pharmacolibrary.Interfaces.PartialSubstance (Identity and physicochemical constants of one drug (Drugs.Substances)).

Information

Sipuleucel-T is an immunostimulant used to treat prostate cancer. It is an approved medicine, mainly used in the United States, but its marketing authorisation in the European Union has been withdrawn.

Summary written by glm-5.3-flash from Wikidata Q424057 and the WHO ATC classification and the EMA medicines list; not checked by a person.

name:sipuleucel-T
ATC codes:L03AX17
DrugBank:DB06688
Wikidata:Q424057

Parameters

TypeNameDefaultDescription
Stringname (from PartialSubstance)""INN / common name
String[:]atcCodes (from PartialSubstance)fill("", 0)all WHO ATC codes of the drug
StringdrugbankId (from PartialSubstance)""e.g. DB00758
StringpubchemCid (from PartialSubstance)""PubChem compound id
StringchebiId (from PartialSubstance)""ChEBI id (number)
StringwikidataId (from PartialSubstance)""e.g. Q410238
Stringformula (from PartialSubstance)""molecular formula
Modelica.Units.SI.MolarMassM (from PartialSubstance)0molar mass; 0 = unknown
ReallogP (from PartialSubstance)Modelica.Constants.infoctanol-water partition coefficient (log10); inf = unknown